Author:
Khanolkar Rutvij A.,Kalra Amit,Kinzel Megan,Pratt Laura M.,Dharmani-Khan Poonam,Chaudhry Ahsan,Williamson Tyler S.,Daly Andrew,Morris Don G.,Khan Faisal M.,Storek Jan
Subject
Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy
Reference61 articles.
1. Pathophysiology of graft-versus-host disease;Ferrara;Seminars in hematology,2006
2. Understanding the alloresponse: new approaches to graft-versus-host disease prevention;Teshima;Seminars in hematology,2002
3. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation;Mielcarek;Blood,2016
4. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation,2008
5. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献